Unique visual stimulation may be new treatment for Alzheimer’s
Noninvasive technique reduces beta amyloid plaques in mouse models of Alzheimer’s disease.
Noninvasive technique reduces beta amyloid plaques in mouse models of Alzheimer’s disease.
Picower Institute director awarded for her research on brain development, neurological disorders, and Alzheimer’s disease.
Study finds a complex series of molecular, cellular, circuit and network-level changes contribute to the progression of Alzheimer's.
Over half a century at MIT, Corkin made lasting contributions to the biology of memory and cognitive disorders.
Neuroscientists retrieve missing memories in mice with early Alzheimer’s symptoms.
Enhanced-sensitivity NMR could reveal new clues to how proteins fold.
Combining MRI and other data helps machine-learning systems predict effects of neurodegenerative disease.
Team from MIT's Computer Science and Artificial Intelligence Lab detects dementia using AI and a digital pen.
MIT’s Picower Institute to partner on four projects with Case Western Reserve University.
Study of epigenomic modifications reveals immune basis of Alzheimer's disease.
Model indicates that diverse research approaches to the disease would be a rewarding investment.
Collaboration unites Picower Institute at MIT with MD Anderson Cancer Center and Baylor College of Medicine.
New study finds long-overlooked cells help the brain respond to visual stimuli.
In clinical trial, mixture developed at MIT appears to help overcome loss of connections between brain cells.
Neuroscientists show that HDAC2 enzyme could be a good target for new drugs.